CDK2 and cancer: Perturbations to these regulatory pathways may contribute in part to cancer progression seen in cells that overexpress cyclin A,1 as the interactions that mediate these regulatory pathways would be in direct competition with unphosphorylated p27 for binding to CDK2-cyclin A as has been previously proposed.20, 45